zepbound tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Weight Loss Injections &

avium infection by raising Glutathione levels, mitigating oxidative stress, and fostering a positive immune response

The economic impact extends beyond individual costs, with GLP-1 therapies driving 6.7% of total drug costs and representing about half of all drug spending increases in 2024 ^25

Nestle, for instance, launched its Vital Pursuit frozen meal brand in late 2024, initially without a "GLP-1 Friendly" label, but added one after customer feedback

And if appetite is so low that even shakes feel impossible, talk to your doctor about adjusting your dose

Are GLP-1 treatments safe

The results of the TRANSCEND-T2D-1 trial, published in March 2026, showed that participants with type 2 diabetes mellitus, who took retatrutide 12mg, lost an average of 16.8% of their body weight at 40 weeks